Risk factors for thrombosis in the follow-up period
| Risk factor . | Thrombosis (N = 25) . | Controls (N = 79) . | Hazard ratio . | |||
|---|---|---|---|---|---|---|
| Univariate . | 95% CI . | Multivariate . | 95% CI . | |||
| Age, y (mean ± SD) | 42.4 ± 14.2 | 45.3 ± 14.7 | 1.0 | 0.97-1.02 | — | — |
| Male sex no. (%) | 8 (32) | 14 (18) | 3.3 | 1.4-8.0 | 4.4 | 1.5-13.1 |
| aCL titre, GPL units (mean ± SD) | 95 ± 85 | 84 ± 91 | 1.0 | 0.99-1.01 | — | — |
| G isotype, no. (%) | 22 (88) | 64 (81) | 1.7 | 0.5-5.6 | — | — |
| Associated autoimmune diseases, no.(%) | 10 (40) | 39 (49) | 0.6 | 0.2-1.1 | — | — |
| Arterial risk factors, no. (%) | 8 (32) | 26 (33) | 0.9 | 0.4-2.2 | — | — |
| Venous risk factors, no. (%) | 10 (40) | 12 (15) | 2.7 | 1.2-6.3 | 3.3 | 1.3-8.5 |
| Aspirin prophylaxis, no. (%) | 7 (28) | 30 (38) | 0.4 | 0.1-1.1 | — | — |
| Risk factor . | Thrombosis (N = 25) . | Controls (N = 79) . | Hazard ratio . | |||
|---|---|---|---|---|---|---|
| Univariate . | 95% CI . | Multivariate . | 95% CI . | |||
| Age, y (mean ± SD) | 42.4 ± 14.2 | 45.3 ± 14.7 | 1.0 | 0.97-1.02 | — | — |
| Male sex no. (%) | 8 (32) | 14 (18) | 3.3 | 1.4-8.0 | 4.4 | 1.5-13.1 |
| aCL titre, GPL units (mean ± SD) | 95 ± 85 | 84 ± 91 | 1.0 | 0.99-1.01 | — | — |
| G isotype, no. (%) | 22 (88) | 64 (81) | 1.7 | 0.5-5.6 | — | — |
| Associated autoimmune diseases, no.(%) | 10 (40) | 39 (49) | 0.6 | 0.2-1.1 | — | — |
| Arterial risk factors, no. (%) | 8 (32) | 26 (33) | 0.9 | 0.4-2.2 | — | — |
| Venous risk factors, no. (%) | 10 (40) | 12 (15) | 2.7 | 1.2-6.3 | 3.3 | 1.3-8.5 |
| Aspirin prophylaxis, no. (%) | 7 (28) | 30 (38) | 0.4 | 0.1-1.1 | — | — |
— indicates not significant.